Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA) — CONCERTO

Early Rheumatoid Arthritis Clinical Trial

Official title:
A Double-Blind, Randomized, Parallel-Arm, Multicenter Study to Determine the Dose Response of Methotrexate (MTX) in Combination Therapy With Adalimumab in Subjects With Early Rheumatoid Arthritis (CONCERTO)

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the effects of different doses of methotrexate (MTX) when taken with adalimumab in subjects with early rheumatoid arthritis (RA).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01185301
Study type	Interventional
Source	AbbVie
Contact
Status	Completed
Phase	Phase 3
Start date	October 2010
Completion date	September 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01768923` - Early RA Vascular Randomised Controlled Study	N/A
Completed	`NCT01762176` - Early RA MRI Early Intensive Treatment Study	N/A
Recruiting	`NCT03755258` - Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid Arthritis	Phase 1
Recruiting	`NCT03389711` - INCMNSZ - Rheumatoid Arthritis Cohort
Completed	`NCT00195663` - Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis	Phase 3
Completed	`NCT04752748` - Power Doppler in Hand Joints of Early RA Patients